Hospitalized COVID-19 patients have shown higher AST levels than ALT, which is unusual outside of specific conditions such as alcohol or drug-related liver damage, ischemic hepatitis, or cirrhosis [17]. This evidence concerns the gene GPT and Cirrhosis.